Volume of distribution in steady state and Bioequivalence [Design Issues]

posted by javier – Spain, 2016-09-14 18:18 (3576 d 18:56 ago) – Posting: # 16637
Views: 7,525

Hi again!

After more time than I would have liked to see, Im coming back to the forum with one question about BE studies

I was reading an article about PK study single dose Healthy volunteers comparing the two drugs,and I was surprised by the Vdss as one pharmacokinetic parameter to match Bioequivalence

I thought Steady state is more appropriate for a multiple dose study, when you can observe the steady state equilibrium (after 3-5 half lives)

So if someone can enlighten about it, i would appreciate it very much

Kinds regards

Javier

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
250 visitors (0 registered, 250 guests [including 12 identified bots]).
Forum time: 13:14 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5